Jonathan Sleeman
Jonathan Sleeman is a Science Advisor for the Midcontinent Region.
Dr. Sleeman leads a team to advance wildlife health science for the benefit of animals, humans, and the environment through multidisciplinary research and technical assistance to federal, state, and tribal agencies as well as internationally as a World Organisation for Animal Health (OIE) Collaborating Centre. He is also an Adjunct Professor at the University of Wisconsin, School of Veterinary Medicine. He has authored over 60 peer-reviewed publications and several book chapters all on the topics of wildlife and ecosystem health. He is active in various scientific organizations, including the Wildlife Disease Association and Ecohealth International, and serves on the OIE’s Working Group on Wildlife. He is board certified by the American College of Zoological Medicine and received his veterinary degree and master’s degree in zoology from the University of Cambridge, England. Previous positions include Director of the Mountain Gorilla Veterinary Center in Rwanda and Wildlife Veterinarian for the Virginia Department of Game and Inland Fisheries.
Professional Experience
May 2009 - June 2023 Center Director, USGS, National Wildlife Health Center
Aug. 2015 - Present Adjunct Professor, Seoul National University, College of Veterinary Medicine, Seoul, Korea
Sept. 2009 - Present Adjunct Professor, Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin
March 2005 - May 2009 Wildlife Veterinarian, Virginia Department of Game and Inland Fisheries
Sept. 2003 - Present Adjunct Assistant Professor, Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee
Aug. 2001 - Oct. 2009 Adjunct Professor, Department of Large Animal Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic and State University
Feb. 2001 - March 2005 Director of Veterinary Services, Wildlife Center of Virginia
Nov. 1997 - June 2000 Postdoctoral Fellow/Clinical Instructor, Zoological and Wildlife Medicine, Colorado State University
June 1997 - Feb. 1998 Interim Project Director, Mountain Gorilla Veterinary Project, Morris Animal Foundation
May 1997 - Oct. 1997 Clinical Instructor/Senior Veterinarian for Knoxville Zoo, Zoological Medicine, The University of Tennessee, College of Veterinary Medicine
July 1995 - April 1997 Field Director, Mountain Gorilla Veterinary Center, Kigali, Rwanda
Education and Certifications
2004 Master of Arts, Zoology, Churchill College, University of Cambridge
1997-2000 Educational Commission for Foreign Veterinary Graduates Certification (DVM equivalency), American Veterinary Medical Association
1989-1992 Bachelor of Veterinary Medicine (Distinction in Pathology, Microbiology and Avian Medicine), University of Cambridge, Department of Veterinary Medicine
1986-1989 Bachelor of Arts, Zoology (Awarded first class honours), Churchill College, University of Cambridge
Special Zoological Medicine Training
1993-1995 Resident, Avian and Zoological Medicine, College of Veterinary Medicine, The University of Tennessee
1992-1993 Intern, Exotic/Zoological Medicine, Coll
Science and Products
One Health best practice case study: Advancing national One Health coordination in the United States through the One Health zoonotic disease prioritization process
Wildlife health capacity enhancement in Thailand through the World Organisation for Animal Health Twinning Program
Stakeholder attitudes and perspectives on wildlife disease surveillance as a component of a One Health approach in Thailand
Wildlife health surveillance: Gaps, needs and opportunities
Future directions to manage wildlife health in a changing climate
Management of diseases in free-ranging wildlife populations
Leading change with diverse stakeholders
Evaluating the risk of SARS-CoV-2 transmission to bats in the context of wildlife research, rehabilitation, and control
Highly pathogenic avian influenza is an emerging disease threat to wild birds in North America
Implications of zoonoses from hunting and use of wildlife in North American arctic and boreal biomes: Pandemic potential, monitoring, and mitigation
Risks posed by SARS‐CoV‐2 to North American bats during winter fieldwork
The virus that causes COVID‐19 likely evolved in a mammalian host, possibly Old‐World bats, before adapting to humans, raising the question of whether reverse zoonotic transmission to bats is possible. Wildlife management agencies in North America are concerned that the activities they authorize could lead to transmission of SARS‐CoV‐2 to bats from humans. A rapid risk assessment conducted in Apri
Animal reservoirs and hosts for emerging alphacoronaviruses and betacoronaviruses
Science and Products
One Health best practice case study: Advancing national One Health coordination in the United States through the One Health zoonotic disease prioritization process
Wildlife health capacity enhancement in Thailand through the World Organisation for Animal Health Twinning Program
Stakeholder attitudes and perspectives on wildlife disease surveillance as a component of a One Health approach in Thailand
Wildlife health surveillance: Gaps, needs and opportunities
Future directions to manage wildlife health in a changing climate
Management of diseases in free-ranging wildlife populations
Leading change with diverse stakeholders
Evaluating the risk of SARS-CoV-2 transmission to bats in the context of wildlife research, rehabilitation, and control
Highly pathogenic avian influenza is an emerging disease threat to wild birds in North America
Implications of zoonoses from hunting and use of wildlife in North American arctic and boreal biomes: Pandemic potential, monitoring, and mitigation
Risks posed by SARS‐CoV‐2 to North American bats during winter fieldwork
The virus that causes COVID‐19 likely evolved in a mammalian host, possibly Old‐World bats, before adapting to humans, raising the question of whether reverse zoonotic transmission to bats is possible. Wildlife management agencies in North America are concerned that the activities they authorize could lead to transmission of SARS‐CoV‐2 to bats from humans. A rapid risk assessment conducted in Apri